BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14692521)

  • 21. Primary cutaneous T-cell lymphoma: review and current concepts.
    Siegel RS; Pandolfino T; Guitart J; Rosen S; Kuzel TM
    J Clin Oncol; 2000 Aug; 18(15):2908-25. PubMed ID: 10920140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of clonality in cutaneous T cell lymphoma and associated diseases.
    Wood GS
    Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K; Yawalkar N; Jones D; Kupper TS
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of blood immunophenotyping and clonality testing in the management of cutaneous T-cell lymphomas].
    Bouthemy C; Beldi-Ferchiou A; Ortonne N; Delfau-Larue MH; Ingen-Housz-Oro S; Molinier-Frenkel V
    Ann Dermatol Venereol; 2017 Apr; 144(4):315-322. PubMed ID: 28242099
    [No Abstract]   [Full Text] [Related]  

  • 25. Dendritic cells and cutaneous T-cell lymphomas.
    Ni X; Duvic M
    G Ital Dermatol Venereol; 2011 Apr; 146(2):103-13. PubMed ID: 21505396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination therapy for cutaneous T-cell lymphoma.
    Muche JM; Sterry W
    Clin Exp Dermatol; 2002 Oct; 27(7):602-7. PubMed ID: 12464157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulomatous slack skin syndrome: Report of a unique case.
    Maheswari SU; Sampath V; Ramesh A
    Indian J Dermatol Venereol Leprol; 2018; 84(2):169-173. PubMed ID: 29067930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of HLA class I dependent immunogenic peptides from clonotypic TCRbeta expressed in cutaneous T-cell lymphoma.
    Zeng J; Müller-Berghaus J; Nguyen XD; Klüter H; Schönhaber H; Song M; Schwinn N; Schadendorf D; Goerdt S; Eichmüller S; Dippel E
    Int J Cancer; 2006 Nov; 119(10):2476-80. PubMed ID: 16858680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
    Lan TT; Brown NA; Hristov AC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythrodermic CTCL: updated clues to diagnosis and treatment.
    Bernengo MG; Quaglino P
    G Ital Dermatol Venereol; 2012 Dec; 147(6):533-44. PubMed ID: 23149699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infantile-onset cutaneous T-cell lymphoma.
    Tsianakas A; Kienast AK; Hoeger PH
    Br J Dermatol; 2008 Dec; 159(6):1338-41. PubMed ID: 18717674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of cutaneous T-cell lymphoma: molecular diagnosis, pathogenesis, therapy and future directions.
    Dippel E; Klemke CD; Goerdt S
    Onkologie; 2003 Oct; 26(5):477-83. PubMed ID: 14605466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmacytoid dendritic cells, a role in neoplastic prevention and progression.
    Lombardi VC; Khaiboullina SF; Rizvanov AA
    Eur J Clin Invest; 2015 Jan; 45 Suppl 1():1-8. PubMed ID: 25524580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. γδ T-cell lymphoma mimicking Sézary syndrome.
    Bauer W; Spazierer D; Klein I; Stary G; Wöhrl S; Wagner SN; Knobler R; Müllauer L; Stingl G
    Acta Derm Venereol; 2012 Mar; 92(2):166-8. PubMed ID: 21918793
    [No Abstract]   [Full Text] [Related]  

  • 37. Photopheresis: present and future aspects.
    Edelson RL
    J Photochem Photobiol B; 1991 Jul; 10(1-2):165-71. PubMed ID: 1955944
    [No Abstract]   [Full Text] [Related]  

  • 38. Cutaneous T-cell lymphoma sparing resolving dermatomal herpes zoster lesions: an unusual phenomenon and implications for pathophysiology.
    Twersky JM; Nordlund JJ
    J Am Acad Dermatol; 2004 Jul; 51(1):123-6. PubMed ID: 15243537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens.
    Agbay RL; Torres-Cabala CA; Patel KP; Merril ED; Duvic M; Quesada A; Prieto VG; Aung PP; Loghavi S; Young KH; Hu S; Ferrufino-Schmidt MC; Tetzlaff M; Li S; Medeiros LJ; Miranda RN
    Am J Surg Pathol; 2017 Apr; 41(4):431-445. PubMed ID: 28248813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contribution of immunotherapy to the treatment of T-cell lymphoma of the skin].
    Bagot M; Boumsell L; Bensussan A
    Presse Med; 1999 Nov; 28(34):1911-6. PubMed ID: 10587730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.